NSAID Panel Highlights Challenge Of Getting Comparative Safety Claim
This article was originally published in The Pink Sheet
Executive Summary
Does wide public health concern warrant flexibility in regulatory standards for safety claims? Advisory panel on cardiovascular risk of NSAIDs spotlights dual challenge of accurately determining drug risks and communicating risks in informative way.